DGS8 inhibitors belong to a specific chemical class of compounds designed to modulate the activity of Diacylglycerol Kinase Subtype 8 (DGS8). DGS8 is an enzyme involved in the regulation of diacylglycerol levels and lipid signaling pathways within cells. Inhibitors of DGS8 are designed to selectively target this enzyme and interfere with its function, potentially affecting lipid signaling cascades and cellular responses.
The mechanism of action of these inhibitors typically involves direct interaction with DGS8 or its catalytic site, disrupting its enzymatic activity and altering the balance of diacylglycerol in cells. Researchers use DGS8 inhibitors to gain insights into the specific functions and molecular interactions involving this enzyme in different cellular contexts. Understanding the structural characteristics and mechanisms of DGS8 inhibitors is crucial for advancing knowledge in this area and may have broader implications for future research in lipid signaling and related fields.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Desipramine hydrochloride | 58-28-6 | sc-200158 sc-200158A | 100 mg 1 g | $66.00 $117.00 | 6 | |
Desipramine is a tricyclic antidepressant that acts as an inhibitor of SLC6A2, leading to increased levels of norepinephrine in the synapse. | ||||||
Nisoxetine hydrochloride | 57754-86-6 | sc-203646 sc-203646A | 10 mg 50 mg | $136.00 $468.00 | 3 | |
Nisoxetine is a selective inhibitor of SLC6A2, similar to atomoxetine, used in research to investigate the role of norepinephrine reuptake in various physiological processes. | ||||||
Talopram hydrochloride | 7013-41-4 | sc-364752 sc-364752A | 10 mg 50 mg | $169.00 $712.00 | ||
Talopram is a selective SLC6A2 inhibitor that has been used in research to study the effects of norepinephrine reuptake inhibition. | ||||||